$2.09
N/A
Last update: Nov 5, 9:09 AM
Seres Therapeutics Inc
MCRBNASDAQ
Seres Therapeutics (MCRB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.07 | $-2.16 | $-1.85 | $-1.92 |
| Actual | $-1.63 | $0.47 | $-2.08 | $-1.76 |
| Surprise | -52.3% | +121.8% | -12.4% | +8.33% |
| Revenue | ||||
| Estimate | $5.1M | $179000 | — | $5.9M |
| Actual | $593000 | $736000 | $358000 | $438000 |
| Surprise | -88.4% | +311.2% | — | -92.5% |
| Metric | Q4 '26E |
|---|---|
| Earnings Per Share (Non-GAAP) | |
| Consensus | $-1.09 |
| Revenue | |
| Consensus | $5.1M |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $-1.63 | $-1.07 | -52.3 % |
| Q2 | Aug 5, 2026 | $0.47 | $-2.16 | 121.8 % |
| Q1 | May 5, 2026 | $-2.08 | $-1.85 | -12.4 % |
| Q4 | Mar 12, 2026 | $-1.76 | $-1.92 | 8.33 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $593.00K | $5.12M | -88.4 % |
| Q2 | Aug 5, 2026 | $736.00K | $179.00K | 311.2 % |
| Q4 | Mar 12, 2026 | $438.00K | $5.88M | -92.5 % |
| Q3 | Nov 5, 2025 | $351.00K | $5.88M | -94.0 % |
